Total Payments
$63,170
2022 Payments
$8,033
Companies
8
Transactions
110
Medicare Patients
1,597
Medicare Billing
$190,085
Payment Breakdown by Category
Other$51,750 (81.9%)
Food & Beverage$8,024 (12.7%)
Travel$3,357 (5.3%)
Education$39.14 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $51,750 | 25 | 81.9% |
| Food and Beverage | $8,024 | 56 | 12.7% |
| Travel and Lodging | $3,357 | 26 | 5.3% |
| Education | $39.14 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $31,581 | 32 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $19,626 | 37 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $7,973 | 21 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,857 | 16 | $0 (2017) |
| Philips Electronics North America Corporation | $87.22 | 1 | $0 (2018) |
| United Therapeutics Corporation | $18.11 | 1 | $0 (2021) |
| Mylan Specialty L.P. | $16.60 | 1 | $0 (2017) |
| PFIZER INC. | $11.44 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $8,033 | 4 | GlaxoSmithKline, LLC. ($8,033) |
| 2021 | $16,052 | 14 | GlaxoSmithKline, LLC. ($16,034) |
| 2020 | $7,207 | 6 | GlaxoSmithKline, LLC. ($7,207) |
| 2019 | $162.11 | 4 | GlaxoSmithKline, LLC. ($162.11) |
| 2018 | $6,477 | 23 | Sunovion Pharmaceuticals Inc. ($6,234) |
| 2017 | $25,239 | 59 | Sunovion Pharmaceuticals Inc. ($13,392) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/18/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 04/13/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $107.95 | General |
| Category: RESPIRATORY | ||||||
| 12/21/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Travel and Lodging | Cash or cash equivalent | $21.28 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $94.23 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2021 | United Therapeutics Corporation | TYVASO (Drug) | Education | In-kind items and services | $18.11 | General |
| Category: PAH | ||||||
| 07/22/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: RESPIRATORY | ||||||
| 06/24/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 06/24/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Travel and Lodging | Cash or cash equivalent | $28.00 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $111.60 | General |
| Category: RESPIRATORY | ||||||
| 04/08/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 04/08/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Travel and Lodging | Cash or cash equivalent | $56.00 | General |
| Category: RESPIRATORY | ||||||
| 03/25/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $123.02 | General |
| Category: RESPIRATORY | ||||||
| 03/11/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 02/11/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 04/23/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: RESPIRATORY | ||||||
| 01/03/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 318 | 495 | $132,006 | $41,575 |
| 2022 | 8 | 342 | 489 | $123,550 | $38,028 |
| 2021 | 9 | 473 | 629 | $154,790 | $56,231 |
| 2020 | 8 | 464 | 644 | $151,350 | $54,251 |
Total Patients
1,597
Total Services
2,257
Medicare Billing
$190,085
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 196 | $58,800 | $18,880 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 159 | $31,800 | $10,138 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 64 | $25,600 | $9,161 | 35.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $7,000 | $2,157 | 30.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 16 | 16 | $2,816 | $354.84 | 12.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 16 | 16 | $2,048 | $313.06 | 15.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 14 | 14 | $1,302 | $296.99 | 22.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 16 | 16 | $2,640 | $274.08 | 10.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 194 | $58,200 | $18,054 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 166 | $33,200 | $10,824 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 59 | $23,600 | $8,202 | 34.8% |
| 94617 | Test for exercise-induced spasm of lung airways | Facility | 2022 | 11 | 11 | $1,320 | $297.24 | 22.5% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 14 | 14 | $630.00 | $260.10 | 41.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 15 | 15 | $1,725 | $150.20 | 8.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 15 | 15 | $2,475 | $128.61 | 5.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 15 | 15 | $2,400 | $111.28 | 4.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 86 | 163 | $53,300 | $22,734 | 42.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 145 | 193 | $51,950 | $19,370 | 37.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 108 | 133 | $26,600 | $9,522 | 35.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $8,000 | $2,777 | 34.7% |
| 94617 | Exercise test for spasm of lung airways with ekg | Facility | 2021 | 24 | 25 | $3,000 | $700.75 | 23.4% |
| 94618 | Test for exercise-induced lung stress | Facility | 2021 | 24 | 26 | $1,170 | $489.06 | 41.8% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 22 | 23 | $2,645 | $232.99 | 8.8% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 24 | 25 | $4,125 | $217.00 | 5.3% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 24 | 25 | $4,000 | $188.00 | 4.7% |
About Dr. Thomas Morris, M.D
Dr. Thomas Morris, M.D is a Pulmonary Disease healthcare provider based in Brockton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083724553.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Morris, M.D has received a total of $63,170 in payments from pharmaceutical and medical device companies, with $8,033 received in 2022. These payments were reported across 110 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($51,750).
As a Medicare-enrolled provider, Morris has provided services to 1,597 Medicare beneficiaries, totaling 2,257 services with total Medicare billing of $190,085. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Brockton, MA
- Active Since 08/30/2006
- Last Updated 04/16/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083724553
Products in Payments
- TRELEGY ELLIPTA (Drug) $31,572
- BEVESPI AEROSPHERE (Drug) $7,973
- UTIBRON (Drug) $6,136
- LONHALA MAGNAIR (Drug) $5,384
- Utibron (Drug) $850.00
- DS Cpap Auto Core-HT (Device) $87.22
- STIOLTO (Drug) $63.57
- TYVASO (Drug) $18.11
- Perforomist (Drug) $16.60
- SPIRIVA RESPIMAT (Drug) $15.92
- ELIQUIS (Drug) $11.44
- SPIRIVA (Drug) $9.93
- BROVANA (Drug) $9.32
- ANORO (Drug) $5.41
- ANORO ELLIPTA (Drug) $4.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.